Influence of serum Cysatin C level on short-term prognosis of patients with ischemic heart failure
-
摘要: 目的:探讨血清胱抑素 C (CysC)水平与缺血性心力衰竭患者近期预后的关系。方法测定76例缺血性心衰患者及46例正常人血清 CysC、BUN 和 Scr 浓度等指标,记录缺血性心衰患者住院期间及出院3个月内主要心血管事件、病死率和再入院率。结果心功能 I 级者血清 CysC 水平较对照组显著升高(P <0.05),随着 NYHA 心功能分级级别增高,血清 CysC水平明显升高(P <0.05)。缺血性心衰患者高血清 CysC 组患者心血管事件、住院病死率、3个月病死率和再入院率都明显增加,与血清 CysC 正常组比较差异有统计学意义(P <0.05)。结论血清 CysC 水平与缺血性心衰患者近期预后有密切的关系,血清 CysC 可作为缺血性心衰患者近期心血管事件及死亡的预测因子。Abstract: Objective To explore the influence of serum Cystatin C(CysC)level on short-term prognosis of patients with ischemic heart failure(IHF).Methods Serum level of CysC,BUN and Scr in the 76 patients with IHF and 46 normal people were detected.The clinical outcomes, major cardiac events,mortality during hospitalization,re-admission rate were compared.Results The level of serum CysC in heart function class I group was significantly better than that in the con-trol group (P <0.05).It increased with the higher class of NYHA heart functional classification (class Ⅳ cardiac function >class Ⅲ>class Ⅱ,respectively)(P <0.05).Compared with normal CysC group,the major cardiac events,mortality and re-admission rate were significantly higher in high CysC group(P <0.05).Conclusion Serum level of CysC is closely related with short-term prognosis of patients with IHF,and it is a predictor for major cardiac events and death in patients with IHF.
-
Keywords:
- ischemic heart failure /
- renal insufficiency /
- Cystatin C
-
-
胡秀全. 连续性血液净化治疗重症心力衰竭合并肾衰竭患者 18 例疗效观察 [J]. 实用临床医药杂志, 2013, (14):71. 冯绍明, 龚英峰, 裴荣光. 血清胱抑素 C 与早期高血压肾损害的相关性研究 [J]. 实用临床医药杂志, 2013, (13):121. 陈灏珠. 心脏病学 [M]. 北京:人民卫生出版社, 2003.407. 中华医学会心血管病学分会. 慢性收缩性心力衰竭治疗建议 [J]. 中华心血管病杂志, 2002(1):7. SHLIPAK M G, SARNAK M J, KATZ R. Cystatin C and the risk of death and cardiovascular events among el-derly persons [J]. New England Journal of Medicine, 2005, (20):2049. Sarnak M J, Katz R, Stehman-Breen C O. Cystatin C concentration as a risk factor for heart failure in older adults [J]. ANNALS OF INTERNAL MEDICINE, 2005(7):497. FILLER G, BOKENKAMP A, HOFMANN W. Cys-tatin C as a marker of GFR history, indications, and future research [J]. CLINICAL BIOCHEMISTRY, 2005(1):1. 王超权. 慢性心力衰竭患者血胱抑素浓度变化及临床意义 [J]. 现代实用医学, 2010(2):193. Moran A, Kata R, Smith N L. Cystatin C concentra-tion as a predictor of systolic and diastolic heart failure [J]. Journal of Cardiac failure, 2008(1):19. 卓奕春, 陈雪丽, 周子杰. 血清胱抑素 C 联合尿微量白蛋白检测在糖尿病肾病早期诊断中的应用价值 [J]. 中国医学创新, 2012, (12):85.
计量
- 文章访问数: 313
- HTML全文浏览量: 37
- PDF下载量: 0